Since June 12, 2023, HHC has been banned in France.
HHC, a new form of synthetic cannabis, is raising concerns.
Hexahydrocannabinol, better known as HHC, is a new form of synthetic cannabis that has appeared on the French market. Like CBD, HHC is a non-psychoactive compound that does not produce a “high.” However, unlike CBD, HHC is produced in a laboratory and not extracted from the cannabis plant. François Braun advocates for a swift ban on HHC.Faced with the growing popularity of HHC, François Braun, a leading figure in the French health sector, has expressed his concern. According to him, it is crucial to act quickly to regulate this new compound before it spreads further. “We must quickly close the door on these new substances,” Braun stated. He emphasizes that even though HHC is currently legal in France, this does not mean it is risk-free. Furthermore, Braun is concerned that HHC, as a synthetic product, could be modified to produce psychoactive effects.
The Need for Clear Regulation
Braun’s call for swift regulation of HHC underscores the need for clear legislation regarding cannabis products. As France continues to debate the legalization of cannabis for recreational use, the emergence of HHC and other synthetic products raises new questions. Should all synthetic products be banned, or only those that pose a health risk? How can we ensure that these products are not used for illegal recreational purposes? These are questions that legislators will need to answer as they navigate the ever-evolving landscape of cannabis and its derivatives.While the future of HHC in France remains uncertain, one thing is clear: the debate on cannabis, whether natural or synthetic, is far from over.
